Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abstracts of the 14th Tunisian Congress of Nuclear Medicine, Tunis, May 2 & 3, 2025.

La Tunisie medicale·2026
Same author

Evaluation of choroidal thickness changes in patients with migraine using optical coherence tomography.

Revue neurologique·2025
Same author

Optical coherence tomography in multiple sclerosis: A Tunisian tertiary center study.

Journal francais d'ophtalmologie·2024
Same author

Hyperhomocysteinemia prevalence among patients with venous thromboembolism.

Future science OA·2024
Same author

Screening for toxic retinopathy due to antimalarial drugs in Tunisia.

Journal francais d'ophtalmologie·2023
Same author

A rare association of Salzmann's nodular degeneration of cornea and dermatopathia pigmentosa reticularis.

Journal francais d'ophtalmologie·2022

Related Experiment Video

Updated: Jun 14, 2026

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel
07:26

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel

Published on: June 29, 2015

[Multiple arterial thrombosis in Behçet's disease].

A Kallel1, M I Miladi, S Marzouk

  • 1Service de neurologie, hôpital universitaire Habib Bourguiba, CP 3029 Sfax, Tunisie.

La Revue De Medecine Interne
|April 6, 2010
PubMed
Summary

Behcet's disease can cause rare but severe arterial thrombosis, including in the carotid and pulmonary arteries. Further research is needed to understand its pathogenesis and optimize treatment for this rare vascular complication.

More Related Videos

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
08:50

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis

Published on: January 9, 2026

Ferric Chloride-Induced Arterial Thrombosis and Sample Collection for 3D Electron Microscopy Analysis
03:57

Ferric Chloride-Induced Arterial Thrombosis and Sample Collection for 3D Electron Microscopy Analysis

Published on: March 17, 2023

Related Experiment Videos

Last Updated: Jun 14, 2026

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel
07:26

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel

Published on: June 29, 2015

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
08:50

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis

Published on: January 9, 2026

Ferric Chloride-Induced Arterial Thrombosis and Sample Collection for 3D Electron Microscopy Analysis
03:57

Ferric Chloride-Induced Arterial Thrombosis and Sample Collection for 3D Electron Microscopy Analysis

Published on: March 17, 2023

Area of Science:

  • Vascular Medicine
  • Rheumatology
  • Immunology

Background:

  • Behcet's disease (BD) is a multisystemic vasculitis with unknown etiopathogeny.
  • Vascular involvement is common in BD, with venous thrombosis (30%) being most frequent.
  • Arterial involvement is rare (2.7–7%) but often severe and life-threatening.

Observation:

  • A 45-year-old Tunisian male presented with Behcet's disease.
  • The patient exhibited bifocal arterial involvement.
  • Specific manifestations included right internal carotid artery thrombosis and bilateral proximal pulmonary artery thrombosis.

Findings:

  • The case highlights a rare instance of extensive arterial thrombosis in Behcet's disease.
  • The patient presented with simultaneous thrombosis in a major cerebral artery and the pulmonary arteries.
  • This presentation underscores the potential severity of vascular complications in BD.

Implications:

  • The pathogenesis of arterial thrombosis in Behcet's disease remains unclear.
  • Effective therapeutic strategies for managing extensive arterial involvement in BD require further investigation.
  • This case prompts further research into the mechanisms underlying BD-associated arterial thrombosis and its management.